Difference between revisions of "Thymus"

Jump to navigation Jump to search
643 bytes added ,  21:19, 28 February 2014
Line 194: Line 194:
Features:<ref name=Ref_WMSP147>{{Ref WMSP|147}}</ref>
Features:<ref name=Ref_WMSP147>{{Ref WMSP|147}}</ref>
*Cytologically malignant - variable morphology.
*Cytologically malignant - variable morphology.
**[[Squamous cell carcinoma]] is the most common (73% of cases).<ref name=pmid23866799>{{Cite journal  | last1 = Zhao | first1 = Y. | last2 = Zhao | first2 = H. | last3 = Hu | first3 = D. | last4 = Fan | first4 = L. | last5 = Shi | first5 = J. | last6 = Fang | first6 = W. | title = Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases. | journal = Ann Thorac Surg | volume = 96 | issue = 3 | pages = 1019-24 | month = Sep | year = 2013 | doi = 10.1016/j.athoracsur.2013.04.078 | PMID = 23866799 }}</ref>
**[[Squamous cell carcinoma]] is the most common (65-73% of cases<ref name=pmid23319214>{{Cite journal  | last1 = Thomas de Montpréville | first1 = V. | last2 = Ghigna | first2 = MR. | last3 = Lacroix | first3 = L. | last4 = Besse | first4 = B. | last5 = Broet | first5 = P. | last6 = Dartevelle | first6 = P. | last7 = Fadel | first7 = E. | last8 = Dorfmuller | first8 = P. | title = Thymic carcinomas: clinicopathologic study of 37 cases from a single institution. | journal = Virchows Arch | volume = 462 | issue = 3 | pages = 307-13 | month = Mar | year = 2013 | doi = 10.1007/s00428-013-1371-y | PMID = 23319214 }}</ref><ref name=pmid23866799>{{Cite journal  | last1 = Zhao | first1 = Y. | last2 = Zhao | first2 = H. | last3 = Hu | first3 = D. | last4 = Fan | first4 = L. | last5 = Shi | first5 = J. | last6 = Fang | first6 = W. | title = Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases. | journal = Ann Thorac Surg | volume = 96 | issue = 3 | pages = 1019-24 | month = Sep | year = 2013 | doi = 10.1016/j.athoracsur.2013.04.078 | PMID = 23866799 }}</ref>).
*+/-Squamous differentiation.
*+/-Squamous differentiation.


Line 212: Line 212:
===IHC===
===IHC===
Features:<ref name=Ref_WMSP147>{{Ref WMSP|147}}</ref>
Features:<ref name=Ref_WMSP147>{{Ref WMSP|147}}</ref>
*CD5 +ve.<ref name=Ref_PBoD708>{{Ref PBoD|708}}</ref>
*CD5 +ve (90% of cases<ref name=pmid23319214/>).<ref name=Ref_PBoD708>{{Ref PBoD|708}}</ref>
*CD7+ve.
*CD117 +ve (87% of cases<ref name=pmid23319214/>).
*CD117 +ve.
*CD7 +ve.
*TTF-1 -ve.
*TTF-1 -ve.


48,589

edits

Navigation menu